Frank E.
- Country
- Germany
- Department
- N/A
Research Overview
- Safety and Pharmacokinetic Evaluation of Nurandociguat in Combination with Nitroglycerin in Patients with Coronary Artery Disease
- A Randomized, Placebo‑Controlled Trial of Zenagamtide (NNC0487‑0111) in Obese Patients with HFpEF or HFmrEF to Reduce CV Death and HF Hospitalization
- An open-label, multi-center, non-randomized pivotal Phase 3 study to evaluate the efficacy and safety of [18F]florbetaben Positron Emission Tomography (PET) imaging to diagnose cardiac AL amyloidosis
Data & Insights
Has run more than one trial at 550 of 1174 partner sites.
Specializations
Heart Failure Research
This investigator specializes in studying various forms of heart failure, with particular emphasis on novel therapeutic approaches for acute decompensated heart failure and non-ischemic cardiomyopathy.
- Prevention strategies in heart failure
- Gene therapy applications
- Combinatorial treatment approaches
Cardiomyopathy Studies
Focused on advancing treatments for various forms of hypertrophic cardiomyopathy, including both obstructive and non-obstructive variants. Research extends to innovative therapeutic agents and comparative treatment efficacy.
- Obstructive hypertrophic cardiomyopathy
- Non-obstructive cardiomyopathy
- Novel therapeutic compounds
Specialized Cardiac Conditions
Investigates complex cardiac conditions including Takotsubo syndrome, cardiac amyloidosis, and pulmonary hypertension associated with left heart disease.
- Aortic stenosis management
- Cardiac imaging techniques
- Cardiovascular biomarkers
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.